title: Chronic vanadyl sulfate (VOSO4) oral treatment is associated with desensitization of VOSO4-induced contractile response in isolated gastric smooth muscle cells.
authors.affiliation: Laboratoire de Pharmacologie (UPRES 2035), Montpellier, France.
authors.forename: A
authors.initials: A
authors.lastname: Cadène
authors.forename: M L
authors.initials: ML
authors.lastname: Soulié
authors.forename: P L
authors.initials: PL
authors.lastname: Teissèdre
authors.forename: R
authors.initials: R
authors.lastname: Magous
authors.forename: J J
authors.initials: JJ
authors.lastname: Serrano
authors.forename: J P
authors.initials: JP
authors.lastname: Bali
authors.forename: G
authors.initials: G
authors.lastname: Cros
mesh_terms: D000284:Administration, Oral; D000818:Animals; D004334:Drug Administration Schedule; D004353:Drug Evaluation, Preclinical; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D066298:In Vitro Techniques; D008297:Male; D009119:Muscle Contraction / Q000187:drug effects*; D009131:Muscle, Smooth, Vascular / Q000187:drug effects; D051381:Rats; D017208:Rats, Wistar; D013270:Stomach; D017968:Vanadium Compounds / Q000627:therapeutic use*
chemical_list: D007004:Hypoglycemic Agents; D017968:Vanadium Compounds; C034028:vanadyl sulfate